Basic science and clinical aspects of vascular anomalies
- PMID: 16012263
- DOI: 10.1097/01.mop.0000171322.76429.80
Basic science and clinical aspects of vascular anomalies
Abstract
Purpose of review: Patients with vascular and lymphatic anomalies are often 'medical orphans' ascertained through distinct medical specialists. Multidisciplinary vascular anomalies programs provide focused expertise in diagnosis and treatment for patients. National and international workshops on vascular anomalies are fostering clinical and basic science research to enhance our understanding of vascular development and vascular anomalies. Herewith is presented an update of recent advances in the study of vascular/lymphatic anomalies.
Recent findings: New original findings include (1) the identification of distinct cell surface markers and other cellular properties in hemangiomas and vascular malformations relevant to vascular development, (2) the discovery of novel genetic mutations and susceptibility genes in patients with vascular anomalies, (3) recognition of new risk stratifications and clinical issues for patients with hemangiomas and vascular malformations, and (4) the elucidation of sequelae from the disorders as well as side effects of recent and previous therapies for vascular anomalies.
Summary: Vascular anomalies are an attractive model for the study of human disorders of vasculogenesis and angiogenesis. The etiology of these disorders is unclear and likely represents a multifactorial process. Clinical clues are leading to scientific investigations that may enable targeted therapies, prevention strategies, or both.
Comment in
-
Recent developments in neonatal dermatology.Curr Opin Pediatr. 2005 Aug;17(4):480. doi: 10.1097/01.mop.0000171323.76429.c9. Curr Opin Pediatr. 2005. PMID: 16012259 No abstract available.
Similar articles
-
Current management of hemangiomas and vascular malformations.Clin Plast Surg. 2005 Jan;32(1):99-116, ix. doi: 10.1016/j.cps.2004.10.001. Clin Plast Surg. 2005. PMID: 15636768 Review.
-
[Item 111 - UE 4 Hemangiomas and skin vascular malformations].Ann Dermatol Venereol. 2015 Jun;142 Suppl 2:S51-7. doi: 10.1016/j.annder.2015.02.014. Epub 2015 Apr 4. Ann Dermatol Venereol. 2015. PMID: 25846472 French. No abstract available.
-
Pyogenic granulomas of infancy masquerading as strawberry hemangiomas.Pediatrics. 1992 Dec;90(6):989-91. Pediatrics. 1992. PMID: 1437442 No abstract available.
-
Diagnosis and treatment of cutaneous vascular lesions.Am Fam Physician. 1998 Feb 15;57(4):765-73. Am Fam Physician. 1998. PMID: 9490999 Review.
-
Congenital lymphatic malformations.Ann N Y Acad Sci. 2008;1131:185-94. doi: 10.1196/annals.1413.016. Ann N Y Acad Sci. 2008. PMID: 18519970 Review.
Cited by
-
Integrated WGCNA and PPI Network to Screen Hub Genes Signatures for Infantile Hemangioma.Front Genet. 2021 Jan 15;11:614195. doi: 10.3389/fgene.2020.614195. eCollection 2020. Front Genet. 2021. PMID: 33519918 Free PMC article.
-
Treatment with propranolol for infantile hemangiomas: A case series of 106 infants.Exp Ther Med. 2015 Jul;10(1):51-54. doi: 10.3892/etm.2015.2485. Epub 2015 May 8. Exp Ther Med. 2015. PMID: 26170911 Free PMC article.
-
Inhibition of angiogenesis mediated by extremely low-frequency magnetic fields (ELF-MFs).PLoS One. 2013 Nov 14;8(11):e79309. doi: 10.1371/journal.pone.0079309. eCollection 2013. PLoS One. 2013. PMID: 24244477 Free PMC article.
-
Histopathological reporting of paediatric cutaneous vascular anomalies in relation to proposed multidisciplinary classification system.J Clin Pathol. 2006 Dec;59(12):1278-82. doi: 10.1136/jcp.2006.038240. Epub 2006 Jun 2. J Clin Pathol. 2006. PMID: 16751300 Free PMC article.
-
Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting.Int J Mol Sci. 2018 Apr 13;19(4):1192. doi: 10.3390/ijms19041192. Int J Mol Sci. 2018. PMID: 29652858 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials